Inventor · disambiguated record
Andrew K. Dilger
Also filed as: DILGER ANDREW · DILGER ANDREW K · DILGER ANDREW KARL
19 granted patents·10 pending applications·27 citations·filing 2013–2024
90Inventor score
Top patents by PatentIndex Score
29 records- 0196US9453018B2Pyrimidinones as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 27, 2016·13 cites·17 claims
- 0289US12209086B2FGFR3 inhibitor compoundsLILLY CO ELI·Filed 2023·Granted Jan 28, 2025·1 cites·44 claims
- 0387US11878976B2FGFR3 inhibitor compoundsLILLY CO ELI·Filed 2022·Granted Jan 23, 2024·1 cites·37 claims
- 0487US11053247B2Pyrimidinones as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 6, 2021·2 cites·9 claims
- 0586US10336754B2Pyrimidinones as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 2, 2019·2 cites·17 claims
- 0679US10676477B2Factor XIa macrocycle inhibitors bearing a non-aromatic P2' groupBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 9, 2020·2 cites·12 claims
- 0778US9777001B2Macrocycles with aromatic P2′ groups as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 3, 2017·3 cites·11 claims
- 0878US2025122196A1Fgfr3 inhibitor compoundsLILLY CO ELI·Filed 2024·Application pending·0 cites
- 0977US12428421B2Pyrimidinones as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 30, 2025·0 cites·31 claims
- 1074US9409908B2Dihydropyridone p1 as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 9, 2016·1 cites·14 claims
- 1173US10611776B2Spiroheptane salicylamides and related compounds as inhibitors of rockBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 7, 2020·1 cites·17 claims
- 1270US9920075B2Triazolopyridine and triazolopyrimidine inhibitors of myeloperoxidaseBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Mar 20, 2018·1 cites·9 claims
- 1363US2025049765A1Bicyclo [3.2.0] heptane bis(amide) rxfp1 agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1461US2016368923A1Pyrimidinones as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 1560US2024368193A1Kras inhibitorsLILLY CO ELI·Filed 2024·Application pending·0 cites
- 1659US10273236B2Macrocyclic factor XIa inhibitors bearing heterocyclic groupsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 30, 2019·0 cites·11 claims
- 1758US10829501B2Spiroheptane salicylamides and related compounds as inhibitors of ROCKBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Nov 10, 2020·0 cites·5 claims
- 1857US2024343736A1Kras inhibitorsLILLY CO ELI·Filed 2024·Application pending·0 cites
- 1955US2018162821A1Factor xia macrocycles with novel p1 groupsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 2054US9951071B2Dihydropyridone P1 as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 24, 2018·0 cites·7 claims
- 2154US2017342071A1Macrocyclic factor xia inhibitors condensed with heterocyclesBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 2252US12065505B2Antibodies and antigen binding peptides for factor XIa inhibitors and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Aug 20, 2024·0 cites·18 claims
- 2352US2019144393A1Factor xia macrocycles with novel p1 groupsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 2449US2023151010A1Crystalline forms of (9r, 135s)-13- {4-[5-chloro-2-(4-chloro-1h,2,3- triazol- 1 -yl)phenyl] -6-oxo- 1,6-dihydropyrimidin- 1-yl}-3-(difluoromethyl)-9-methyl-3,4,7,15- tetraazatricyclo [ 12.3.1.0 2·6] octadeca- 1(18), 2(6), 4, 14, 16-pentaen-8-oneBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2546US2017057961A1Macrocyclic factor xia inhibitors condensed with heterocyclesBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 2639US10696674B2Spirolactams as inhibitors of ROCKBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 30, 2020·0 cites·13 claims
- 2738US11008317B2Triazolopyridine inhibitors of myeloperoxidase and/or EPXBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 18, 2021·0 cites·5 claims
- 2838US10287288B2Factor XIa macrocyclic inhibitors bearing alkyl or cycloalkyl P2' moietiesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted May 14, 2019·0 cites·11 claims
- 2937US10316035B2Triazolopyridine inhibitors of myeloperoxidaseBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 11, 2019·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Andrew K. Dilger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →